. Role of ATP-sensitive K ϩ channels in electrophysiological alterations during myocardial ischemia: a study using Kir6.2-null mice. Am J Physiol Heart Circ Physiol 288: H352-H357, 2005; doi:10.1152/ajpheart.00695.2004.-The role of cardiac ATPsensitive K ϩ (KATP) channels in ischemia-induced electrophysiological alterations has not been thoroughly established. Using mice with homozygous knockout (KO) of Kir6.2 (a pore-forming subunit of cardiac KATP channel) gene, we investigated the potential contribution of KATP channels to electrophysiological alterations and extracellular K ϩ accumulation during myocardial ischemia. Coronaryperfused mouse left ventricular muscles were stimulated at 5 Hz and subjected to no-flow ischemia. Transmembrane potential and extracellular
CARDIAC ELECTROPHYSIOLOGY varies in a dynamic fashion during myocardial ischemia (1) . Ever since K ϩ was postulated to be a major excitant (6) , particular attention has been devoted to the rise in extracellular K ϩ concentration ([K ϩ ] o ) during myocardial ischemia (30) . The increase in [K ϩ ] o causes depolarization of the resting membrane, reduction of the upstroke velocity, and shortening of the APD. These electrophysiological changes are pivotal in the genesis of reentrant arrhythmias (1, 9) . Nevertheless, the precise mechanism underlying extracellular K ϩ accumulation is still a matter for debate. Since numerous studies demonstrated that inhibition of the ATPsensitive K ϩ (K ATP ) channels by sulfonylureas lessens the rise in [K ϩ ] o during early ischemia (7, 11, 15, 27, 31) (10, 26, 28) . Thus the results obtained so far with K ATP channel openers and blockers are not conclusive.
The molecular structure of the cardiac K ATP channel has been defined as an octametric complex of four pore-forming Kir6.2 and four SUR2A sulfonylurea receptors (20) . Using mice with homozygous knockout of Kir6.2 gene (Kir6.2 KO) (14) , previous studies in our laboratory (23, 24) showed that neither K ATP channel openers nor metabolic inhibition abbreviates action potentials in Kir6.2 KO mouse ventricular myocytes. Therefore, Kir6.2 KO mice have no functional sarcolemmal K ATP channels in cardiac cells and are potentially useful to examine whether K ϩ efflux through K ATP channels is mainly involved in extracellular K ϩ accumulation in ischemic hearts. In this study, we used coronary-perfused Kir6.2 KO mouse hearts and investigated the electrophysiological alterations and extracellular K ϩ accumulation during the early phase of myocardial ischemia.
MATERIALS AND METHODS

Kir6.2-deficient mice.
A mouse line deficient in KATP channels was generated by targeted disruption of the gene coding for Kir6.2, as described previously (14) . C57BL/6 mice were used as controls because the KO animals had been backcrossed to a C57BL/6 strain for five generations. All procedures complied with the Guide for the Care and Use of Laboratory Animals (NIH Pub. No. 85-23, 1996 revision) and were approved by the Institutional Animal Care and Use Committee of Chiba University.
Coronary-perfused ventricular preparations. Mice were anesthetized with urethane (1.5 g/kg ip) and anticoagulated with heparin (100 U/kg iv). The hearts were then dissected out and mounted on a Langendorff apparatus. The right and left atria, right ventricular free wall, and septum were removed. The preparation was then mounted in a recording chamber and coronary perfused at a constant flow (2 ml/min) with Tyrode solution containing (in mM) 125 NaCl, 4 KCl, 1.8 NaH 2PO4, 0.5 MgCl2, 2.7 CaCl2, 5.5 glucose, and 25 NaHCO3 and gassed with 95% O2-5% CO2. The surface of the preparation was superfused with substrate-free hypoxic Tyrode solution (5 ml/min) to minimize direct O 2 diffusion from the surface of the preparation into the myocardium interior. The hypoxic Tyrode solution had the same composition as given above, except that it contained no glucose and was gassed with 95% N 2-5% CO2. The temperature of these solutions was maintained at 36 Ϯ 0.5°C. The coronary flow was completely stopped by closing the electromagnetic valve placed close to the aorta, producing no-flow ischemia of the entire preparation.
Action potential recordings. The basal portion of the preparation was stimulated at 5 Hz throughout the experiment with the use of a pair of platinum electrodes (2-ms rectangular pulses at 2ϫ threshold intensity). Action potentials were recorded from a cell that was located deep (Ͼ5 cell layers) in the subepicardial surface by use of a 3 M KCl-filled microelectrode (tip resistance 10 -20 M⍀ Measurements of effective refractory period and conduction time. Effective refractory periods (ERPs) were determined by the standard extrastimulus technique. Action potentials were evoked by electrical field stimulation at 5 Hz (2-ms rectangular pulses at 2ϫ threshold intensity). Extrastimuli (S2) were interposed at varying intervals during periods of continuous basic stimuli (S1). ERP was defined as the longest S1-S2 interval that failed to generate an active response. Conduction time was designated as the interval from the stimulus artifact to the action potential upstroke.
Chemicals. Glibenclamide (Sigma, St. Louis, MO) was dissolved as a 10 mM stock solution in dimethyl sulfoxide. Dimethyldichlorosilane was purchased from Wako (Osaka, Japan).
Data acquisition and statistical analysis. Records were simultaneously displayed on an oscilloscope, digitized with an analog-todigital converter (Mac Lab/2e; ADInstruments, Castle Hill, Australia), and stored on disk in a personal computer (PowerMac 7300/180; Macintosh) with a MacLab data acquisition system (AD Instruments). All data are presented as means Ϯ SE. The number of experiments is shown as n. Intergroup comparisons were made by ANOVA followed by Fisher's post hoc test for multiple groups. A value of P Ͻ 0.05 was regarded as significant.
RESULTS
Alterations in action potentials. Representative recordings of action potentials before and after 2 and 10 min of ischemia are shown in Fig. 1 . No-flow ischemia shortened APD and produced depolarization of resting membrane potential (RMP) in wild-type (WT) hearts (Fig. 1A) . The APD in Kir6.2 KO hearts was prolonged at 2 min of ischemia, and the abbreviation of APD was not observed after 10 min of ischemia. The ischemia-induced shortening of APD was attenuated in glibenclamide (1 M)-treated (WTϩGlb) hearts. On the other hand, the depolarization of RMP was observed in both Kir6.2 KO and WTϩGlb hearts (Fig. 1 , B and C). Figures 2 and 3 summarize the time courses of changes in APD 90 and RMP during no-flow ischemia, respectively. There were no significant differences in the basal action potential parameters between WT and Kir6.2 KO hearts. During no-flow ischemia, APD 90 decreased significantly from 67.4 Ϯ 2.7 to 19.4 Ϯ 3.5 ms (n ϭ 6, P Ͻ 0.05) after 10 min of ischemia in WT hearts. The APD 90 shortening during ischemia was significantly attenuated by glibenclamide, and the APD 90 change after 10 min of ischemia was not statistically significant in WTϩGlb hearts [from 61.8 Ϯ 1.7 to 51.3 Ϯ 7.1 ms; n ϭ 6, P ϭ not significant (NS)]. In Kir6.2 KO hearts, APD 90 shortening was not observed over 10 min (from 61.2 Ϯ 3.4 to 84.0 Ϯ 5.7 ms; n ϭ 6, P ϭ NS) and APD 90 was rather prolonged transiently at 1.5 min of ischemia (101.0 Ϯ 5.3 ms, P Ͻ 0.05). RMP decreased markedly during the first 2 min and thereafter gradually declined during no-flow ischemia in WT hearts (from Ϫ74.0 Ϯ 2.4 to Ϫ57.8 Ϯ 2.7 mV; n ϭ 7, P Ͻ 0.05). A similar time course of RMP changes was observed in both Kir6.2 KO (from Ϫ72.0 Ϯ 0.8 to Ϫ57.9 Ϯ 1.6 mV; n ϭ 6, P Ͻ 0.05) and WTϩGlb (from Ϫ74.8 Ϯ 1.8 to Ϫ59.2 Ϯ 1.5 mV; n ϭ 6, P Ͻ 0.05) hearts, and there were no significant differences among the three groups. Slowing of conduction. Superimposed action potentials obtained at control conditions and after 8 min of ischemia are shown in Fig. 5A . In all groups, the time interval from the stimulus artifact to the action potential upstroke (conduction time) was prolonged after ischemia. Figure 5B summarizes the time-dependent changes of conduction time during ischemia. In WT hearts, the conduction time was prolonged from 8.8 Ϯ 0.4 to 25.2 Ϯ 2.2 ms (n ϭ 5, P Ͻ 0.05). Similar changes in conduction time were observed in WTϩGlb hearts (from 9.0 Ϯ 1.1 to 28.0 Ϯ 3.2 ms; n ϭ 5, P Ͻ 0.05). In Kir6.2 KO hearts, time-dependent slowing of conduction was more pronounced compared with WT and WTϩGlb hearts (from 9.8 Ϯ 0.6 to 61.8 Ϯ 10.0 ms; n ϭ 5, P Ͻ 0.01).
Relation between ERP and APD. The relationship between action potential repolarization and refractoriness during ischemia was examined by measuring ERP. Figure 6 summarizes the time course of changes in ERP and ERP-to-APD 90 ratio during the first 5 min of ischemia. There was no significant difference in the ERPs among the three groups under control (preischemic) conditions. Despite the ischemia-induced shortening of APD 90 , ERP did not change during ischemia (from 51.8 Ϯ 4.2 to 46.3 Ϯ 7.61 ms; n ϭ 7, P ϭ NS) in WT hearts. Consequently, the ERP-to-APD 90 ratio in WT hearts was increased during ischemia (from 0.73 Ϯ 0.04 to 2.01 Ϯ 0.19; n ϭ 7, P Ͻ 0.05). In Kir6.2 KO hearts, ERP was prolonged during the initial 1-2 min of ischemia (from 50.5 Ϯ 5.4 to 83.3 Ϯ 8.9 ms; n ϭ 6, P Ͻ 0.05) and then declined to the preischemic level during continued ischemia. Because this transient prolongation of ERP occurred synchronously with changes in APD 90 (cf. Fig. 2) , the ERP-to-APD 90 ratio was unchanged during ischemia in Kir6.2 KO hearts (from 0.70 Ϯ 0.05 to 0.66 Ϯ 0.09; n ϭ 6, P ϭ NS). In WTϩGlb hearts, ERP did not alter during ischemia (from 45.0 Ϯ 1.6 to 48.0 Ϯ 2.3 ms; n ϭ 5, P ϭ NS) and the ERP-to-APD 90 ratio changed from 0.76 Ϯ 0.03 to 1.24 Ϯ 0.15 (n ϭ 5, P Ͻ 0.05 vs. before ischemia).
DISCUSSION
The involvement and contribution of K ATP channels in the electrophysiological alterations in ischemic myocardium have been extensively characterized on the basis of pharmacological studies using glibenclamide, a blocker of K ATP channels. However, the effect of glibenclamide must be carefully interpreted because of its low degree of specificity (19) . Moreover, Venkatesh et al. (27) reported that the ability of sulfonylureas to block K ATP channel may be compromised when the intracellular ADP concentration is elevated, a condition encountered during myocardial ischemia. Such limited efficacy of sulfonylureas may negate the usefulness of the drugs for qualitative evaluation. One approach to overcoming these problems is the genetic deletion of K ATP channels. Recently, a K ATP channel KO mouse was generated by disruption of the Kir6.2 gene (14), and our previous studies (23, 24) revealed that Kir6.2 forms the pore region of the cardiac K ATP channels. In the present study, coronary-perfused ventricular preparations of Kir6.2 KO mice were subjected to no-flow ischemia to obtain a more definitive answer as to the debated roles of the K ATP channels in ischemia-induced electrophysiological alterations.
The present experiments show that the ischemia-induced shortening of APD was not observed in Kir6.2 KO hearts ( Figs.  1 and 2 ). In addition, glibenclamide greatly attenuated APD shortening during ischemia. Therefore, our data add further support to the widely accepted notion that activation of K ATP Fig. 2 . Time course of the changes in action potential duration measured at 90% repolarization (APD90) during ischemia in WT (n ϭ 6), Kir6.2 KO (n ϭ 6), and WTϩGlb (n ϭ 6) mouse hearts. Values are expressed as means Ϯ SE. *P Ͻ 0.01 vs. WT. Fig. 3 . Time course of the changes in resting membrane potential (RMP) during ischemia in WT (n ϭ 7), Kir6.2 KO (n ϭ 6), and WTϩGlb (n ϭ 6) mouse hearts. Values are expressed as means Ϯ SE. channels is responsible for APD shortening during myocardial ischemia (18) . Somewhat unexpectedly, we found that APD was rather prolonged transiently during the early phase of ischemia in Kir6.2 KO hearts. Apart from the activation of K ATP channels, marked electrophysiological alterations occur in ischemic myocardium, thereby modulating action potential configuration (1) . For example, lysophosphatidylcholine, a lipid metabolite, accumulates rapidly in ischemic myocardium and has been shown to inhibit inward rectifier K ϩ current (I K1 ) (3, 12) . The transient outward current (I to ) has been shown to decrease under condition of metabolic stress (25) . Thus the inhibition of outward currents other than the K ATP channel current might lead to the prolongation of APD when complete K ATP channel blockade is achieved by the genetic deletion.
A rise in [K ϩ ] o is a major factor contributing to the development of lethal ventricular arrhythmias during acute myocardial ischemia (6, 9) . It has been reported that the change in [K ϩ ] o typically occurs with triphasic time courses, the initial fast rise followed by a secondary plateau phase and a third slower increase (30) . Because previous studies showed that the sulfonylureas modulate the initial rate of rise of [K ϩ ] o (7, 11, 15, 27, 31) , our attention has been focused primarily on the first two (initial rise and subsequent plateau) phases. In the present experiments, we continuously monitored [K ϩ ] o for a period of 10 min of ischemia and found that [K ϩ ] o increased in a biphasic manner comprising an initial rising phase and a second plateau phase. A third phase was observed when the monitoring was continued up to 20 min (data not shown). The most striking finding is that [K ϩ ] o in Kir6.2 KO hearts increased during early ischemia in a manner similar to that of WT hearts (Fig. 4) . Furthermore, glibenclamide did not affect extracellular K ϩ accumulation during early ischemia, despite effective suppression of the ischemia-induced shortening of APD (Figs. 2 and 4) . Although major support for the K ATP channel hypothesis has come from pharmacological studies, the suitability of glibenclamide for assessment of involvement of K ATP channels has been seriously questioned (19) . Our study using Kir6.2 KO mice definitely indicates that K ATP channel activation is not the primary cause of the extracellular K ϩ accumulation. In terms of the mechanism(s) of ischemiainduced increase in [K ϩ ] o , several possibilities such as activation of Na (16) , and lactate transport (21) have been raised. Recently, Shivkumar et al. (22) proposed that intracellular Na ϩ accumulation produces passive K ϩ loss in hypoxic myocardium and K ϩ channels including K ATP channel function only as a K ϩ diffusion pathway. Our findings that extracellular K ϩ accumulation similarly occurred in K ATP channel-deficient myocardium may be consistent with their hypothesis.
In the present investigation, the ischemia-induced depolarization of RMP occurred similarly in both WT and Kir6.2 KO hearts (Fig. 3) . These findings can be interpreted as showing that the resulting [K ϩ ] o increase then depolarizes RMP in ischemic hearts. In principle, the depolarization of RMP inactivates Na ϩ channels, thereby causing the conduction delay (9) . In the present study, conduction time was prolonged in all groups, accompanied by the depolarization of RMP. However, it should be mentioned that, despite the fact that similar changes in RMP occurred in WT and Kir6.2 KO hearts, the conduction delay was more pronounced in Kir6.2 KO hearts. Propagation of electrical activity is dependent not only on the stimulatory current provided by the action potential upstroke but also on the resistive elements in the current circuit, i.e., gap junction resistance. An increase in the intracellular concentration of Ca 2ϩ can lead to a reduction of gap junction conductance (4). Indeed, a previous study documented that cellular uncoupling occurs in ischemic myocardium and the Ca 2ϩ antagonist verapamil prevents the ischemia-induced conduction slowing (8) . We previously found (24) that it took more time for the cessation of ventricular contraction during global ischemia in isolated Kir6.2 KO hearts compared with WT hearts, probably because of the lack of APD shortening and resultant Ca 2ϩ influx during plateau phase. In addition, the increase in left ventricular end-diastolic pressure during ischemia was more marked in Kir6.2 KO hearts than in WT hearts, suggesting that greater Ca 2ϩ overload might occur in ischemic heart cells of Kir6.2 KO mice. Moreover, the third phase of K ϩ accumulation, which occurs with electrical cell-to-cell uncoupling (2), was observed earlier in Kir6.2 KO hearts. Therefore, it is reasonable to assume that the inhibition of gap junction caused by Ca 2ϩ overload might produce a greater conduction delay in Kir6.2 KO hearts.
Activation of K ATP channels can theoretically be expected to increase the incidence of reentrant arrhythmias in ischemic hearts, because of APD shortening and K ϩ efflux (32) . However, we found that extracellular K ϩ accumulation is not primarily attributable to the activation of K ATP channels. In addition, as evidenced in Fig. 6 , opening of K ATP channels did not shorten ERP but rather produced postrepolarization refractoriness (5, 13) . Activation of K ATP current might counteract the depolarizing current, thereby contributing to the establishment of postrepolarization refractoriness. As discussed above, activation of K ATP channels may rather lead to a decrease in Ca 2ϩ influx during ischemia, which in turn could prevent the conduction delay. Thus opening of K ATP channels is by no means proarrhythmic and may rather reduce the incidence of arrhythmias by preventing early and delayed afterdepolarizations as well as producing postrepolarization refractoriness. Unfortunately, however, neither WT nor Kir6.2 KO mice developed ischemic ventricular arrhythmias in our experimental condition, perhaps because global ischemia produces little heterogeneity in the electrophysiological alterations. Further studies using larger mammals would be required to establish the contribution of K ATP channels to ischemia-related arrhythmias.
It is well known that configuration of cardiac action potentials varies from species to species. Mouse ventricular cells show a relatively short action potential with negative plateau voltage. Because a different action potential configuration reflects a difference in the balance between inward and outward currents, the relative impact of K ATP channel activation on APD shortening and extracellular K ϩ accumulation during myocardial ischemia may differ between mouse hearts and those of larger mammals. Therefore, the extrapolation of the results observed in this study to larger mammals including humans should be made with caution.
The most important conclusion of this study using the Kir6.2 KO heart is that K ATP channel activation is not the primary cause of the extracellular K ϩ accumulation during early ischemia, although it contributes to the shortening of APD. These findings provide new insights concerning antiarrhythmic and arrhythmogenic potential of K ATP channels in ischemic hearts.
